This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bioleaders Corporation. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Hiroshi Uyama: Innovator in Hyaluronidase Inhibition
Introduction
Hiroshi Uyama is a notable inventor based in Shiga, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of compositions that enhance skin health and alleviate allergic symptoms. His innovative work has led to the creation of a unique hyaluronidase inhibitor.
Latest Patents
Hiroshi Uyama holds a patent for a hyaluronidase inhibitor containing poly-gamma-glutamic acid (PGA) as an effective component. This invention relates to a composition that maintains skin elasticity and improves allergy symptoms. The compositions utilize PGA to effectively inhibit the activity of hyaluronidase, an enzyme that degrades hyaluronic acid in the skin dermis. By doing so, these compositions help maintain skin moisturization and elasticity while also relieving allergic symptoms by inhibiting the permeability of inflammatory cells. He has 1 patent to his name.
Career Highlights
Uyama is associated with Bioleaders Corporation, where he continues to work on innovative solutions in the field of skin health. His research and development efforts have positioned him as a key figure in the industry, contributing to advancements that benefit consumers seeking effective skincare solutions.
Collaborations
Hiroshi Uyama collaborates with talented professionals in his field, including Jae Chul Choi and Moon Hee Sung. These partnerships enhance the research and development process, leading to more effective and innovative products.
Conclusion
Hiroshi Uyama's contributions to the field of biochemistry, particularly through his patent on hyaluronidase inhibitors, demonstrate his commitment to improving skin health and addressing allergic reactions. His work at Bioleaders Corporation and collaborations with other experts further solidify his impact in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
